Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385514452> ?p ?o ?g. }
- W4385514452 endingPage "2322" @default.
- W4385514452 startingPage "2315" @default.
- W4385514452 abstract "Abstract Background Blood telomere length (BTL) is a validated biomarker of aging. ART reduces immunosenescence and has benefits in terms of BTL in people living with HIV (PLWH). However, it has also been observed that ART containing NRTIs, such as tenofovir or abacavir, which are potent inhibitors of human telomerase activity in vitro, might negatively affect BTL. Here we investigated the effects on BTL 1 year after switching to a dual therapy (DT) with dolutegravir + lamivudine versus maintaining a standard triple therapy (TT) with a two-NRTI backbone and an anchor drug. Methods This was a longitudinal, prospective, matched, controlled study that included virologically suppressed adults on stable three-drug ART who either switched at baseline (BL) to DT or maintained TT. The DT and TT groups were 1:1 matched for age, sex, years since HIV diagnosis, years on ART and anchor drug. BTL was assessed by a monochrome multiplex qPCR at BL and after 48 weeks (W48). Results We enrolled 120 PLWH, i.e. 60 participants in each group. At BL, the BTL means were comparable between the two groups (P = 0.973). At W48, viro-immunological status was stable and an overall increase in the mean BTL was observed, i.e., +0.161 (95%CI, 0.054–0.268) (P = 0.004). However, the within-group analysis showed a significant mean BTL gain in the DT group (P = 0.003) but not in the TT group (P = 0.656). Conclusions In this setting of virologically suppressed PLWH, simplifying to dolutegravir + lamivudine was associated with a higher gain in BTL than maintaining triple therapy after the 1 year follow-up. These findings suggest that as a simplification strategy dolutegravir + lamivudine might have a positive effect on BTL." @default.
- W4385514452 created "2023-08-04" @default.
- W4385514452 creator A5016247442 @default.
- W4385514452 creator A5029829647 @default.
- W4385514452 creator A5037360246 @default.
- W4385514452 creator A5041785868 @default.
- W4385514452 creator A5049357858 @default.
- W4385514452 creator A5053575436 @default.
- W4385514452 creator A5066309477 @default.
- W4385514452 date "2023-08-03" @default.
- W4385514452 modified "2023-10-14" @default.
- W4385514452 title "Blood telomere length gain in people living with HIV switching to dolutegravir plus lamivudine versus continuing triple regimen: a longitudinal, prospective, matched, controlled study" @default.
- W4385514452 cites W1974248438 @default.
- W4385514452 cites W1987247332 @default.
- W4385514452 cites W2026761826 @default.
- W4385514452 cites W2027150151 @default.
- W4385514452 cites W2031527589 @default.
- W4385514452 cites W2047905274 @default.
- W4385514452 cites W2082399402 @default.
- W4385514452 cites W2109413245 @default.
- W4385514452 cites W2149868956 @default.
- W4385514452 cites W2162106012 @default.
- W4385514452 cites W2396754576 @default.
- W4385514452 cites W2515425401 @default.
- W4385514452 cites W2591529777 @default.
- W4385514452 cites W2607186390 @default.
- W4385514452 cites W2613655571 @default.
- W4385514452 cites W2809343731 @default.
- W4385514452 cites W2810577492 @default.
- W4385514452 cites W2897264072 @default.
- W4385514452 cites W2974514444 @default.
- W4385514452 cites W3146943745 @default.
- W4385514452 cites W4200064940 @default.
- W4385514452 cites W4206800970 @default.
- W4385514452 cites W4214656079 @default.
- W4385514452 doi "https://doi.org/10.1093/jac/dkad237" @default.
- W4385514452 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37534393" @default.
- W4385514452 hasPublicationYear "2023" @default.
- W4385514452 type Work @default.
- W4385514452 citedByCount "0" @default.
- W4385514452 crossrefType "journal-article" @default.
- W4385514452 hasAuthorship W4385514452A5016247442 @default.
- W4385514452 hasAuthorship W4385514452A5029829647 @default.
- W4385514452 hasAuthorship W4385514452A5037360246 @default.
- W4385514452 hasAuthorship W4385514452A5041785868 @default.
- W4385514452 hasAuthorship W4385514452A5049357858 @default.
- W4385514452 hasAuthorship W4385514452A5053575436 @default.
- W4385514452 hasAuthorship W4385514452A5066309477 @default.
- W4385514452 hasBestOaLocation W43855144521 @default.
- W4385514452 hasConcept C126322002 @default.
- W4385514452 hasConcept C142462285 @default.
- W4385514452 hasConcept C143998085 @default.
- W4385514452 hasConcept C159047783 @default.
- W4385514452 hasConcept C188816634 @default.
- W4385514452 hasConcept C2522874641 @default.
- W4385514452 hasConcept C2777869810 @default.
- W4385514452 hasConcept C2779465607 @default.
- W4385514452 hasConcept C2779502633 @default.
- W4385514452 hasConcept C2780216070 @default.
- W4385514452 hasConcept C2780593183 @default.
- W4385514452 hasConcept C2780727368 @default.
- W4385514452 hasConcept C2781413609 @default.
- W4385514452 hasConcept C2993143319 @default.
- W4385514452 hasConcept C3013748606 @default.
- W4385514452 hasConcept C71924100 @default.
- W4385514452 hasConcept C90924648 @default.
- W4385514452 hasConceptScore W4385514452C126322002 @default.
- W4385514452 hasConceptScore W4385514452C142462285 @default.
- W4385514452 hasConceptScore W4385514452C143998085 @default.
- W4385514452 hasConceptScore W4385514452C159047783 @default.
- W4385514452 hasConceptScore W4385514452C188816634 @default.
- W4385514452 hasConceptScore W4385514452C2522874641 @default.
- W4385514452 hasConceptScore W4385514452C2777869810 @default.
- W4385514452 hasConceptScore W4385514452C2779465607 @default.
- W4385514452 hasConceptScore W4385514452C2779502633 @default.
- W4385514452 hasConceptScore W4385514452C2780216070 @default.
- W4385514452 hasConceptScore W4385514452C2780593183 @default.
- W4385514452 hasConceptScore W4385514452C2780727368 @default.
- W4385514452 hasConceptScore W4385514452C2781413609 @default.
- W4385514452 hasConceptScore W4385514452C2993143319 @default.
- W4385514452 hasConceptScore W4385514452C3013748606 @default.
- W4385514452 hasConceptScore W4385514452C71924100 @default.
- W4385514452 hasConceptScore W4385514452C90924648 @default.
- W4385514452 hasIssue "9" @default.
- W4385514452 hasLocation W43855144521 @default.
- W4385514452 hasLocation W43855144522 @default.
- W4385514452 hasOpenAccess W4385514452 @default.
- W4385514452 hasPrimaryLocation W43855144521 @default.
- W4385514452 hasRelatedWork W1978873194 @default.
- W4385514452 hasRelatedWork W2009577475 @default.
- W4385514452 hasRelatedWork W2135690881 @default.
- W4385514452 hasRelatedWork W2164864370 @default.
- W4385514452 hasRelatedWork W2320051647 @default.
- W4385514452 hasRelatedWork W2998986478 @default.
- W4385514452 hasRelatedWork W3040536113 @default.
- W4385514452 hasRelatedWork W3173702643 @default.
- W4385514452 hasRelatedWork W4235226011 @default.
- W4385514452 hasRelatedWork W4366703691 @default.